






























	 A	series	of	2‐hydroxypyrrolidine/piperidine	derivatives	(4a‐h)/(4i‐m)	were	prepared	byreacting	 2,3‐dihydrofuran	 (2a)/3,4‐dihydro‐2H‐pyran	 (2b)	 with	 various	 heterocyclic
amines	 (3a‐h),	 using	 FeCl3.6H2O	 as	 catalyst.	 The	 synthesized	 compounds	 were












the	 medical	 chemistry	 drug	 armamentarium.	 Pyrrolidine	 and	
its	derivatives	are	widely	used	in	agrochemicals,	photographic	
chemicals,	 corrosion	 inhibitors	 and	 curing	 agent	 for	 epoxy	
resins	and	as	a	catalyst	in	the	manufacture	of	polyurethane	[1‐
4].	 It	 has	 been	 revealed	 from	 the	 literature	 that	 many	
biologically	 active	 alkaloids	 are	 found	 to	 possess	 pyrrolidine	
ring	 system	 [5,6].	 Proline,	 hydroxyproline	 and	 higrine	 are	
amino	acids	which	are	the	derivatives	of	pyrrolidine.	
Dystonia,	 a	 rare	 disorder	 that	 causes	 abnormal	 muscle	
contraction,	results	in	twisting	postures	of	limbs,	trunk	or	face	
[7‐9].	 Procyclidine	 is	 a	 drug,	 which	 is	 the	 derivative	 of	
pyrrolidine,	used	in	the	treatment	of	dystoniaand	also	used	as	
anti‐cholinergic	 drug	 [10].	 The	 most	 wide	 spread	 usage	 of	
calcium	channel	blockers	 (CCB)	 is	 to	decrease	blood	pressure.	
Bepridil	is	a	derivative	of	pyrrolidine	used	as	CCB	drug	[11,12].	
It	 has	 been	 reported	 that	 hydroxy	 substituted	 pyrrolidines	
were	 used	 as	 anticancer	 drugs	 [13‐15].	 Influenza	 is	 an	 acute	
viral	 infection	 of	 the	 upper	 respiratory	 tract	 that	 can	 affect	
millions	of	people	every	year.	Neuraminidase	(NA)	is	one	of	the	
glycoproteins	 exposed	 on	 the	 influenza	 virus	 surface.	 The	
catalytic	 activity	 of	 NA	 is	 essential	 for	 influenza	 virus	
replication	and	 infectivity.	Pyrrolidine	 served	as	a	 scaffold	 for	
substituent’s	 in	 potential	 NA	 inhibitors	 and	 used	 as	 anti‐
influenza	drug	[16‐18].	
Postpartum	 hemorrhage	 (PPH),	 the	 most	 common	
maternal	morbidity	 in	developed	countries	and	a	major	 cause	
of	 death	 worldwide.	 Blood	 loss	 exceeding	 1000	 mL	 is	
considered	physiologically	 significant	 and	 can	 result	 in	hemo‐
dynamic	 instability.	 Even	 with	 appropriate	 management,	
approximately	three	percent	of	vaginal	deliveries	will	result	in	
severe	 post‐partum	 hemorrhage	 [19‐22].	 Carbetocin,	 an	
obstetric	 drug	 used	 to	 control	 postpartum	 hemorrhage	 and	
bleeding	 after	 giving	 birth,	 is	 a	 derivative	 of	 pyrrolidine	 [23‐
25].	Anisomycin,	 a	derivative	of	pyrrolidine	used	 as	 a	 compo‐
nent	 of	 Martin	 Lewis	 agar,	 an	 in‐vitro	 diagnostic	 product	
[26,27].	 Anisomycin	 can	 also	 sensitize	 metastatic	 epithelial	
cells	 to	anoikis	and	reduce	circulating	tumor	cell	 implantation	
in	 vivo.	 Vildagliptin,	 a	 derivative	 of	 pyrrolidine	 has	 been	
employed	to	reduce	hyperglycemia	in	type	2	diabetes	mellitus	
[28‐30].	 Further,	 this	 has	 been	 reported	 that	 the	 pyrrolidine	










Dipipanone	 is	 a	 derivative	 of	 piperidine	used	 as	 analgesic	
[34].	 Narcolepsy	 is	 a	 chronic	 neurological	 disorder	 caused	 by	
the	 brain's	 inability	 to	 regulate	 sleep‐wake	 cycles	 normally.	
People	 with	 narcolepsy	 often	 experience	 disturbed	 nocturnal	
sleep	and	an	abnormal	daytime	sleep	pattern.	Methylphenidate,	
a	derivative	of	piperidine	used	 in	 the	 treatment	of	narcolepsy	
[35,36].	One	of	the	derivatives	of	piperidine,	ethylphenidate	is	a	
potent	psychostimulant	 that	 act	as	both	a	dopamine	 reuptake	
inhibitor	 and	 norepinephrine	 reuptake	 inhibitor,	 meaning	 it	
effectively	 boosts	 the	 levels	 of	 the	 norepinephrine	 and	
dopamine	 neurotransmitters	 in	 the	 brain,	 by	 binding	 to,	 and	
partially	 blocking	 the	 transporter	 proteins	 that	 normally	
remove	those	monoamines	from	the	synaptic	cleft	[37].	
Osteoporosis	 is	 a	 progressive	 bone	 disease	 that	 is	
characterized	by	a	decrease	in	bone	mass	and	density	and	that	
leads	to	an	increased	risk	of	fracture.	The	form	of	osteoporosis	
is	 most	 common	 in	 women	 after	 menopause.	 Raloxifene	 is	 a	
derivative	 of	 piperidine	 used	 as	 a	 drug	 for	 the	 treatment	 of	
osteoporosis	 [38‐40].	 Androgenic	 alopecia	 is	 hair	 loss	 that	
occurs	 due	 to	 an	 underlying	 susceptibility	 of	 hair	 follicles	 to	
androgenic	miniaturization.	It	is	the	common	cause	of	hair	loss	
and	will	 affect	 upto	70%	of	men	 and	40%	of	women	at	 some	
point	in	their	lifetime.	Minoxidil,	a	derivative	of	piperidine	used	
to	 treat	 baldness	 and	 hair	 loss	 [41,42].	 The	 structures	 of	
pharmacological	 important	 compounds	 possess	 pyrrolidine/	
piperidine	moieties	are	shown	in	Figure	1.	
In	 the	 view	 of	 the	 above	 remarkable	 considerations,	 an	














and	 used	 without	 any	 further	 purification	 unless	 otherwise	
noted.	 Melting	 points	 were	 determined	 on	 an	 EZ‐Melt	
automated	melting	point	apparatus	without	corrections.	All	the	
reactions	 were	 carried	 out	 under	 the	 inert	 atmosphere	 of	
nitrogen.	 Analytical	 TLC	 was	 performed	 on	 pre‐coated	
aluminum	sheets	of	silica	(60F254)	and	visualized	by	short‐wave	
UV	 light	 at	 λ	 254	 nm.	 Flash	 column	 chromatography	 was	
carried	 out	 on	 silica	 gel	 (230‐400	 mm)	 and	 semi‐automated	
purification	 was	 carried	 out	 on	 a	 Biotage	 SP1	 purification	
system,	using	SNAP	cartridges.	Solvent	systems	are	reported	by	
column	volume	(CV)	with	the	solvent	flow	rate	as	stated.	
Absorption	 maxima	 (νmax)	 are	 quoted	 in	 wave	 numbers	
(cm‐1).	 1H	 NMR	 spectra	 were	 recorded	 on	 Bruker400	 MHz	
using	an	internal	deuterium	lock.	Chemical	shifts	are	expressed	
in	ppm,	 the	 following	 internal	 references	were	used	CDCl3	 (H:	
7.26	ppm),	CD3OD	(H:	3.32	ppm)	and	DMSO‐d6	(H:	2.50	ppm).	
13C	NMR	spectra	were	recorded	on	100	MHz	using	an	internal	
deuterium	 lock.	 The	 following	 internal	 references	were	 used:	
CDCl3	 (C:	 77.0	 ppm),	 CD3OD	 (C:	 49.0	 ppm)	 and	 DMSO‐d6	 (C:	







To	 a	 solution	 of	 5‐(trifluoromethyl)‐1,3,4‐thiadiazol‐2‐
amine	 (3a)	 (200	mg,	 1.18	 mmol)	 in	 acetonitrile	 (5	 mL),	 2,3‐
dihydrofuran	 (2a)	 (99	mg,	 1.4	mmol)	was	 added	 followed	by	
ferric	 chloride	 hexahydrate	 (FeCl3.6H2O)	 (0.59	 mmol)	 at	 0°C.	
The	 reaction	 mixture	 was	 kept	 in	 an	 oil	 bath	 maintained	 at	
60°C	and	stirred	well	for	30	min.	Progress	of	the	reaction	was	
continuously	monitored	 by	 LC/MS.	 The	 reaction	mixture	was	
diluted	with	ethyl	acetate	and	washed	with	water.	The	organic	
layer	was	dried	over	Na2SO4	and	concentrated	by	vacuum.	The	









Hz,	 2H,	 ‐N‐CH2),	 2.15‐2.09	 (m,	 J	 =	 3	 Hz,	 1H,	 O‐CH‐CH2),	 2.01‐












CH‐CH2),	 1.99‐1.82	 (m	 ,	 J	=	3.0	Hz,	3H,	N‐CH2‐CH2+O‐CH‐CH2).	
13C	NMR	(100	MHz,	CDCl3,	δ,	ppm):	183.45	(C‐5),	159.13	(C‐2),	
86.52	(C‐7),	67.46	(C‐10),	32.36	(C‐8),	24.01	(C‐9).	Anal.	calcd.	
for	 C6H9N3OS:	 C,	 42.09,	 H,	 5.30,	 N,	 24.54.	 Found:	 C,	 42.06,	 H,	
5.10,	N,	25.10%.	LC‐MS	(m/z):	172.2	(M+1).	





CH2),	 2.00‐1.90	 (m,	 J	=	 2.0	 Hz,	 3H,	 N‐CH2‐CH2+O‐CH‐CH2).	 13C	
NMR	 (100	 MHz,	 CDCl3,	 δ,	 ppm):	 183.49	 (C‐5),	 158.79	 (C‐3),	
86.54	(C‐7),	67.49	(C‐10),	32.28	(C‐8),	23.99	(C‐9).	Anal.	calcd.	















4‐carboxamide	 (4e):	 Color:	 White	 solid.	 Yield:	 20	 mg,	 80	 %.	





1.79	 (m,	 J	=	6.0	Hz,	2H,	 ‐N‐CH2‐CH2)	1.49‐1.47	 (dd,	 J	=	7.0	Hz,	
3H,	 ‐CH3).	 13C	 NMR	 (100	 MHz,	 CDCl3,	 δ,	 ppm):	 167.21	 (C‐2),	
166.81	(C‐4),	160.47	(C‐5),	145.66	(C‐11),	143.13	(C‐10),	48.49	







1H,	 ‐N‐CH),	 3.72	 (t,	 J	 =	 7.0	 Hz,	 2H,	 ‐N‐CH2),	 3.54	 (m,	 4H,	 ‐N‐
CH2piperidine	 ring),	 2.12‐2.06	 (m,	 2H,	 ‐O‐CH‐CH2),	 1.95‐1.90	
(m,	 2H,	 ‐N‐CH2‐CH2CH2	 piperidine	 ring),	 1.84‐1.74	 (m,	 4H,	 ‐N‐
CH2‐CH2piperidine	 ring),	 1.58‐1.47	 (m,	 2H,	 ‐O‐CH2‐CH2‐).	 13C	
NMR	 (100	 MHz,	 CDCl3,	 δ,	 ppm):	 167.26	 (C‐2),	 163.45	 (C‐4),	
146.38	 (C‐5),	 111.97	 (C‐11),	 86.50	 (C‐7),	 67.08	 (C‐10),	 48.13	
(C‐15),	 43.60	 (C‐19),	 32.27	 (C‐8),	 26.56	 (C‐16),	 25.59	 (C‐18),	
4.50	(C‐24),	23.42	(C‐17).	Anal.	calcd.	forC13H19N3O2S:	C,	55.49,	






Hz,	1H,	 ‐N‐CH‐OH),	 3.64	 (t,	 J	 =	7.0	Hz,	1H,	 ‐NH‐CH),	 3.65‐3.62	
(m,	2H,	‐N‐CH2),	2.00‐1.90	(m,	J	=	2.0	Hz,	4H,	O‐CH‐CH2+‐N‐CH‐
CH2),	1.14	 (m,	6H,	 ‐CH3‐CH‐CH3).	 13C	NMR	(100	MHz,	CDCl3,	δ,	
ppm):	167.37	(C‐2),	161.02	(C‐4),	146.17	(C‐5),	112.70	(C‐11),	






NH‐),	 5.55‐5.51	 (m,	 1H,	 ‐CH‐OH),	 3.87‐3.85	 (m,	 1H,	 ‐NH‐CH),	
3.75‐	3.72	(m,	2H,	‐N‐CH2),	2.14‐2.08	(m,	1H,	‐O‐CH‐CH2),	1.99‐
1.95	 (m,	1H,	 ‐O‐CH‐CH2),	 1.85‐1.77	 (m,	2H,	 ‐N‐CH2‐CH2),	 1.52‐
1.40	(m,	2H,	CH3‐CH2‐),	1.13‐1.09	(m,	3H,	‐CH‐CH3),	0.86	(m,	3H,	
‐CH2‐CH3).	 13C	 NMR	 (100	 MHz,	 CDCl3,	 δ,	 ppm):	 167.10	 (C‐2),	
160.72	 (C‐4),	 145.99	 (C‐5),	 112.96	 (C‐11),	 86.22	 (C‐7),	 67.08	






CH2),	 1.82‐1.76	 (m,	 2	H,	O‐CH‐CH2)	 1.60‐1.54	 (m,	 4	H,	N‐CH2‐
CH2+O‐CH‐CH2‐CH2).	13C	NMR	(100	MHz,	CDCl3,	δ,	ppm):171.18	
(C‐2),	 121.79	 (C‐5),	 118.19	 (C‐12),	 87.22	 (C‐7),	 67.45	 (C‐11),	
32.04	 (C‐8),	 23.81	 (C‐10),	 21.55	 (C‐9).	 Anal.	 calcd.	 for	
C8H10F3N3OS:	 C,	 37.94;	 H,	 3.98;	 N,	 16.59.	 Found:	 C,	 37.14;	 H,	
3.86;	N,	16.65%.	LC‐MS	(m/z):	254.2	(M+1).	





CH2+O‐CH‐CH2‐CH2).	 13C	 NMR	 (100	 MHz,	 CDCl3,	 δ,	 ppm):	
183.45	(C‐5),	159.13	(C‐2),	86.52	(C‐7),	67.46	(C‐11),	32.36	(C‐
8),	 24.01	 (C‐10),	 21.05	 (C‐9).	 Anal.	 calcd.	 for	 C7H11N3OS:	 C,	
45.39,	H,	5.99,	N,	22.68.	Found:	C,	45.26,	H,	5.82,	N,	22.50%.	LC‐
MS	(m/z):	186.2	(M+1).	
1‐(1,2,4‐Thiadiazol‐5‐yl)piperidin‐2‐ol	 (4k):	 Color:	 White	
crystalline	solid.	Yield:	24	mg,	87	%.	M.p.:	140‐141	°C.	1H	NMR	
(400	MHz,	DMSO‐d6,	δ,	ppm):	9.02	(d,	J	=	7.0	Hz,	1H,	‐OH),	8.11	
(s,	1H,	 ‐N‐CH‐N),	 4.80‐	4.76	 (m,	1H,	 ‐CH‐OH),	3.61‐3.43	 (q,	 J	 =	
7.0	Hz,	2H,	‐N‐CH2),	1.87‐1.81	(m,	2	H,	O‐CH‐CH2)	1.71‐1.67	(m,	
4	H,	N‐CH2‐CH2+O‐CH‐CH2‐CH2).	 13C	NMR	 (100	MHz,	CDCl3,	 δ,	
ppm):	 183.49	 (C‐5),	 158.79	 (C‐3),	 86.54	 (C‐7),	 67.49	 (C‐11),	








(m,	 2	 H,	 O‐CH‐CH2)	 1.58‐1.47	 (m,	 4	 H,	N‐CH2‐CH2+O‐CH‐CH2‐
CH2),	1.46‐	1.42	(t,	J	=	7	Hz,	3H,	‐CH3).	13CNMR	(100	MHz,	CDCl3,	
δ,	ppm):	167.48	(C‐12),	161.51	(C‐5),	142.79	(C‐3),	117.72	(C‐
2),	 83.38	 (C‐7),	 64.99	 (C‐11)	 61.08	 (C‐13),	 30.73	 (C‐8),	 24.87	







1H,	 ‐N‐CH‐OH),	3.64	 (t,	 J	 =	7.0	Hz,	1H,	 ‐NH‐CH),	 3.65‐3.62	 (m,	
2H,	 ‐N‐CH2),	 2.00‐1.90	 (m,	 J	 =	 2.0	 Hz,	 4H,	 O‐CH‐CH2+‐N‐CH2‐
CH2),	 1.58‐1.47	 (m,	 2	H,	O‐CH‐CH2‐CH2)1.14	 (m,	 6H,	 ‐CH3‐CH‐
CH3).	13C	NMR	(100	MHz,	CDCl3,	δ,	ppm):	167.37	(C‐12),	161.02	






In	 this	 study,	 a	 series	 of	 2‐hydroxypyrrolidine	 and	
piperidine	 derivatives	 were	 synthesized	 by	 reacting	 different	
heterocyclic	 amine	 (3a‐h)	 and	 2,3‐dihydrofuran	 (2a)	 using	
FeCl3.6H2O	 as	 catalyst.	 Heterocyclic	 amines	 (3a‐h)	 and	
compound	 2a	 reacted	 leads	 to	 2‐hydroxypyrrolidine	 deriva‐
tives	 (4a‐h)	 through	 the	 formation	 of	 oxonium	 ion.	 The	

















































































The	oxonium	 ion	 thus	 formed	was	undergone	cleavage	by	
the	approach	of	amino	group	at	the	5thposition	of	compound	2a	
leads	 to	 ring	 opening	 in	 the	 step	2.	 In	 the	 step	3	 ring	 closure	
occurs	through	N‐atom	of	compound	3a	followed	by	hydrolysis	
yielded	 the	 product	 (Figure	 2).	 In	 the	 present	 study,	 C‐N	
linkage	made	through	FeCl3.6H2O	catalyst	with	excellent	yield.	
FeCl3.6H2O	 showed	 the	 remarkable	 catalytic	 activity	 than	
CeCl3.7H2O	 which	 has	 been	 reported	 earlier.	 Furthermore	 a	
series	 of	 piperidine	 derivatives	 (4i‐m)	 were	 synthesized	 by	
treating	 3,4‐dihydro‐2H‐pyran	 (2b)	 and	 various	 heterocyclic	
amines	(3a‐3d	and	3g).	




as	 solvent.	 In	 this	 condition,	 we	 observed	 the	 formation	 of	
required	 product	 but	 the	 yields	 are	 very	 less	 in	 the	 case	 of	
some	of	the	primary	amine.	We	changed	the	solvents	(Table	1)	
and	 temperature	 (Table	 2),	 but	 results	 are	 not	 much	
encouraging.	Next,	we	focused	the	use	of	different	catalyst.	We	
screened	 a	 series	 of	 catalysts	 Table	 3.	 From	 the	 Table	 3,	 it	 is	
observed	 that	 ferric	 chloride	 hexahydrate	 catalyst	 resulted	
better	yield	than	the	others.	Thus,	our	optimal	conditions	were	






We	 have	 reported	 a	 series	 of	 2‐hydroxypyrrolidine	 and	
























































Spectral	 analyses	 of	 the	 compound	 were	 found	 to	 match	
with	 the	 proposed	 structure.	 Among	 the	 various	 solvent	 and	
catalyst	 used	 acetonitrile	 and	 FeCl3.	 6H2O	 were	 found	 to	 be	
effective	 solvent	 and	 catalyst	 respectively.	 It	 is	 revealed	 from	
the	reaction	conditions,	the	product	formation	favours	at	60	°C.	
The	 compounds	 thus	 synthesized	 using	 this	methodology	 can	
be	 useful	 in	 the	 field	 of	 medicinal	 chemistry.	 The	 biological	
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